Ocular and Inflammatory Diseases
Inflammation is a component of most ocular diseases. Aside from trauma, inflammatory ocular diseases, in aggregate, are the leading cause of blindness worldwide. Aldeyra is currently developing ophthalmic solutions for the treatment of several ocular inflammatory diseases including:
In addition, Aldeyra is developing product candidates for the treatment of other forms of retinal inflammation, potentially including dry age-related macular degeneration, Stargardt disease, geographic atrophy, diabetic macular edema, diabetic retinopathy, posterior uveitis, and retinal vein occlusion.